Cytek Biosciences
CTKB
#5840
Rank
NZ$1.41 B
Marketcap
$11.01
Share price
5.38%
Change (1 day)
9.38%
Change (1 year)

Operating Margin for Cytek Biosciences (CTKB)

Operating Margin as of November 2024 (TTM): -7.42%

According to Cytek Biosciences's latest financial reports and stock price the company's current Operating Margin is -7.42%. At the end of 2023 the company had an Operating Margin of -8.14%.

Operating Margin history for Cytek Biosciences from 2020 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-8.14%-1159.56%
20220.77%-83.45%
20214.64%-70.14%
202015.54%-155.22%
2019-28.15%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.